The Relationship Between Social Anxiety and Anxiety Sensitivity in Young Adults with Methamphetamine Use Disorder
Öz
Objective: Recently, it has been observed that the prevalence of substance use in young adulthood has increased. Comorbidity of anxiety disorders is high in individuals with substance use disorder. In this study, it was aimed to investigate the relationship between anxiety sensitivity and social anxiety in young adults using methamphetamine.
Material and Methods: 101 patients diagnosed with methamphetamine use disorder were included in the study. Participants were evaluated with sociodemographic data form, Addiction Profile Index (BAPI), Symptom Check List (SCL-90-R), Liebowitz Social Anxiety Inventory (LSAI) and Anxiety Sensitivity Index-3 (ASI-3).
Results: It was determined that 70.3% of the subjects with SUD were diagnosed as SAD. ASI-3, SCL-90-R and BAPI scores were statistically significantly higher in the SAD group than in the non-SAD group (p<0.05). A statistically significant positive correlation was found in the SAD group between the LSAI-fear/anxiety subscale scores and ADI-3 total (r=0.26, p<0.05), ADI-3 cognitive(r=0.34, p<0.05) and SCL-90-R total scores (r=0.28, p<0.05). No correlation was found between LSAI scores and ADI-3 total and subscale scores in the non-SAD group (p>0.05).
Conclusion: It can be suggested that anxiety sensitivity is a common risk factor for both methamphetamine use disorder and social anxiety. Social anxiety symptoms should be questioned in individuals with methamphetamine use disorder and substance addiction treatment should be carried out together with social anxiety disorder treatment.
Anahtar Kelimeler
Metamphetamine use disorder, young adult, anxiety sensitivity, social Anxiety
Kaynakça
- Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997 ;54:313-321.
- Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev 2000; 20:149-171.
- Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug Alcohol Depend 2015; 154:1-13.
- Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend. 2004;74:223-234.
- Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008; 27:253-262.
- Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004; 13:181-190.
- Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 1996; 91:81-87.
- McKetin R, Ross J, Kelly E, Baker A, Lee N, Lubman DI, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008; 27:277-285.
- Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R, et al. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict. 2010; 19:385-390.
- Stein DJ, Lim CCW, Roest AM, de Jonge P, Aguilar-Gaxiola S, Al-Hamzawi A, et al. The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Med 2017; 15:143.